New collaboration with MTTlab for Metabolomics applied to invivo studies

Starting from December 2017, Giotto Biotech started a new collaboration with MTTlab. MTTlab delivers both in vitro and in vivo data sets for the preclinical evaluation of investigational compounds which can be used for regulatory submissions, project evaluation, scientific publications and fund raising. MTTlab provides support for client studies or projects from the earliest research stages and assists with both scientific and regulatory challenges to obtain valid results within requested deadlines.

Thanks to this new cooperation, Giotto Biotech and MTTlab intend to wide their services and products offer and to launch new ones.